3000-03-005/ENGOT-ov44/FIRST

An Adaptive Randomized Phase 3 Comparison of Standard Platinum Based Treatment versus Platinum And TSR-042 Followed by Niraparib and TSR-042 Maintenance Therapy in Patients With Epithelial Stage III or IV Cancer of the Ovary, Fallopian Tube, or Peritoneum.